EUVIMEDΑνακαλύψτε το EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Changes in the cortical GABAergic inhibitory system with ageing and ageing‐related neurodegenerative diseases

Wolfgang Taube, Benedikt Lauber

The Journal of Physiology · 2026-01 · 604 (2) · 689-706

DOI: 10.1113/jp285656 ↗

At a glance

Übersichtsarbeit in The Journal of Physiology, published online on 2024-12-25. Written by Wolfgang Taube and 1 co-authors. Institution: Department of Neuroscience and Movement Science, University of Fribourg, Fribourg, Switzerland. Major MEDLINE topics: Aging, Neurodegenerative Diseases, gamma-Aminobutyric Acid, GABAergic Neurons. Cited 16 times so far (Crossref); 134 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Swiss National Science Foundation, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.

ΠερίληψηSubjectsΒιβλιογραφικά στοιχείαCiteRelated studies

Abstract (original language)

The human cortical inhibitory system is known to play a vital role for normal brain development, function, and plasticity. GABA is the most prominent inhibitory neurotransmitter in the CNS and is a key regulator not only for motor control and motor learning, but also for cognitive processes. With ageing and many neurodegenerative pathologies, a decline in GABAergic function in several cortical regions together with a reduced ability to task‐specifically modulate and increase inhibition in the primary motor cortex has been observed. This decline in intracortical inhibition is associated with impaired motor control but also with diminished motor‐cognitive (i.e. dual‐tasking) and cognitive performance (e.g. executive functions). Furthermore, more general well‐being such as sleep quality, stress resistance or non‐specific pain perception are also associated with reduced GABA functioning. The current review highlights the interplay between changes in GABAergic function and changes in motor control, motor‐cognitive and cognitive performance associated with healthy ageing, as well as in seniors with neurodegenerative diseases such as mild cognitive impairment. Furthermore, recent evidence highlighting the ability to up‐ or downregulate cortical inhibition by means of physical exercise programs is presented and discussed. image

Subjects

MeSH terms (MEDLINE)

AgingNeurodegenerative Diseasesgamma-Aminobutyric AcidGABAergic NeuronsCerebral CortexHumansAnimalsCognition

Author keywords

GABAageingcognitivecortical inhibitionmotor controlmotor‐cognitiveneurodegenerative disease

Substances

gamma-Aminobutyric Acid

Authors and institutions

  • Department of Neuroscience and Movement Science, University of Fribourg, Fribourg, Switzerland.

Funding

  • Swiss National Science Foundation
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Cite

APA

Taube, W., & Lauber, B. (2026). Changes in the cortical GABAergic inhibitory system with ageing and ageing‐related neurodegenerative diseases. The Journal of Physiology, 604(2), 689-706. https://doi.org/10.1113/jp285656

Vancouver

Taube W, Lauber B. Changes in the cortical GABAergic inhibitory system with ageing and ageing‐related neurodegenerative diseases. The Journal of Physiology. 2026;604(2):689-706. doi:10.1113/jp285656

BibTeX
@article{Taube2026,
  author = {Taube, Wolfgang and Lauber, Benedikt},
  title = {Changes in the cortical GABAergic inhibitory system with ageing and ageing‐related neurodegenerative diseases},
  journal = {The Journal of Physiology},
  year = {2026},
  volume = {604},
  number = {2},
  pages = {689--706},
  doi = {10.1113/jp285656}
}
Start for free →